世界の気管支内ブロッカー市場は、2025年に7.4百万米ドルと算定されており、2026年には7.63百万米ドルとなる見通しです。2026年から2032年の期間においては年平均成長率（CAGR）3.5%で推移し、2032年には9.4百万米ドルに達すると予測されています。

本レポートは、気管支内ブロッカーメーカー、新規参入企業、および業界バリューチェーン全体の企業に対し、市場全体およびサブセグメント別の収益、生産量、平均価格に関する情報を、企業別、タイプ別、用途別、地域別に提供します。
世界の気管支内ブロッカー市場について、定量的・定性的分析を交えた包括的な概観を提供し、企業関係者が成長戦略の策定、競争環境の評価、現行市場における自社の位置付けの分析、気管支内ブロッカーに関する情報に基づいたビジネス判断を行うことを支援します。気管支内ブロッカー市場の規模、推定値及び予測値の観点から提示し、2025年を基準年として、2021年から2032年までの過去データ及び予測データを収録しております。

報告対象範囲
売上高・数量予測、企業シェア、競争環境、成長要因および市場トレンド

市場セグメンテーション
企業一覧
Teleflex
Cook
PROACT Medical
NexGen Medical
Fuji Systems
Well Lead Medical


タイプ別
5Fr
7Fr
9Fr


用途別
Hospital
Clinic
Others


製品カテゴリー


市場セグメント


地域別
北米（アメリカ、カナダ、メキシコ）
欧州（ドイツ、フランス、イギリス、イタリアなど）
アジア太平洋（中国、日本、韓国、東南アジア、インドなど）
南米（ブラジルなど）
中東・アフリカ（トルコ、GCC諸国、アフリカなど）
本レポートは、世界の気管支内ブロッカー市場を包括的にセグメント化しております。地域別市場規模、タイプ別、用途別、企業別の市場規模も提供されます。より深い洞察を得るため、競争環境、主要競合他社、それぞれの市場順位をプロファイリングし、技術動向や新製品開発についても論じております。

本レポートの構成
第1章：気管支内ブロッカーの定義および調査範囲を明確化し、市場セグメント（タイプ別、用途別など）の概要を提示します。各セグメントの市場規模と将来の成長可能性を網羅し、現在の市場状況の概要を提供するとともに、短期・中期・長期の発展トレンドを分析します
第2章：気管支内ブロッカーメーカーの競争環境について、価格、生産量、価値ベースの市場シェア、最新の開発計画、合併・買収情報を含め詳細に分析します
第3章：気管支内ブロッカーの生産量／生産高および価値を地域・国別に検証し、今後6年間の各地域の市場規模と成長可能性について定量的な評価を提供します
第4章：地域および国レベルでの気管支内ブロッカーの消費動向を分析します。各地域および主要国における市場規模と成長可能性を定量化し、市場開発状況、見通し、対応可能な市場規模、国内生産量を概説します
第5章：気管支内ブロッカーに基づくタイプ別市場セグメントの構造を整理し、各セグメントの市場規模と成長ポテンシャルを明確化することで、企業・投資家によるブルーオーシャン機会の発見を支援します
第6章：用途別に気管支内ブロッカーの市場セグメントを整理し、各分野の市場規模、成長ポテンシャル、需要拡大余地を提示することで、下流市場における有望な参入機会や競争優位の確立に向けた判断材料を提供します
第7章：気管支内ブロッカーの主要プレイヤーを分析し、主要企業の基本情報（製品生産量／生産高、価値、価格、粗利益率、製品ポートフォリオ／新製品導入、最近の動向）を詳細に説明します
第8章：気管支内ブロッカーの上流および下流セグメントを含む業界バリューチェーンをレビューします
第9章：気管支内ブロッカー市場の動向と最新トレンドについて議論します。これには、メーカーにとっての推進要因、制約要因、課題、リスク、米国関税、関連政策分析が含まれます
第10章：主な調査結果と結論をまとめます
第11章：付録

The global Endobronchial Blocker market was valued at US$ 7.4 million in 2025 and is anticipated to reach US$ 9.4 million by 2032, at a CAGR of 3.5% from 2026 to 2032.

The 2025 U.S. tariff policies introduce profound uncertainty into the global economic landscape. This report critically examines the implications of recent tariff adjustments and international strategic countermeasures on Endobronchial Blocker competitive dynamics, regional economic interdependencies, and supply chain reconfigurations.

An endobronchial blocker is a medical device used during certain surgical procedures or critical care situations to selectively block one lung's airway while allowing ventilation of the other lung. It is often used in procedures like thoracic surgeries, lung isolation during one-lung ventilation, or to manage conditions where differential lung ventilation is necessary. The endobronchial blocker is typically placed through a bronchoscope and positioned in the main bronchus of the target lung to occlude the airflow to that lung. This allows the healthcare provider to control the ventilation and airflow to each lung independently, optimizing oxygenation and ventilation during the procedure.

North America key players of Endobronchial Blocker include Cook, Teleflex, Well Lead Medical, etc. The top three players hold a share about 72%. America is the largest market, and has a share about 72%. In terms of product type, 7Fr is the largest segment, accounting for a share of 41%. In terms of application, Hospital is the largest field with a share about 76 percent.

This report delivers a comprehensive overview of the global Endobronchial Blocker market, with both quantitative and qualitative analyses, to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current market, and make informed business decisions regarding Endobronchial Blocker. The Endobronchial Blocker market size, estimates, and forecasts are provided in terms of sales volume (Units) and revenue (US$ millions), with 2025 as the base year and historical and forecast data for 2021–2032.

The report segments the global Endobronchial Blocker market comprehensively. Regional market sizes by Type, by Application, , and by company are also provided. For deeper insight, the report profiles the competitive landscape, key competitors, and their respective market rankings, and discusses technological trends and new product developments.
This report will assist Endobronchial Blocker manufacturers, new entrants, and companies across the industry value chain with information on revenues, sales volume, and average prices for the overall market and its sub-segments, by company, by Type, by Application, and by region.

Market Segmentation
By Company
Teleflex
Cook
PROACT Medical
NexGen Medical
Fuji Systems
Well Lead Medical

Segment by Type
5Fr
7Fr
9Fr

by Application
Hospital
Clinic
Others

Consumption by Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
Europe
Germany
France
U.K.
Italy
Russia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE

Chapter Outline
Chapter 1: Defines the scope of the report and presents an executive summary of market segments (by Type, by Application, , etc.), including the size of each segment and its future growth potential. It offers a high-level view of the current market and its likely evolution in the short, medium, and long term.
Chapter 2: Provides a detailed analysis of the competitive landscape for Endobronchial Blocker manufacturers, covering pricing, sales and revenue shares, latest development plans, and mergers and acquisitions.
Chapter 3: Examines Endobronchial Blocker sales and revenue at the regional and country levels. It quantifies market size and growth potential for each region and its key countries, and outlines market development, outlook, addressable space, and national market size.
Chapter 4: Analyzes segments by Type, detailing the size and growth potential of each segment to help readers identify “blue ocean” opportunities.
Chapter 5: Analyzes market segments by Application, covering the size and growth potential of each segment to help readers identify “blue ocean” opportunities in downstream markets.
Chapter 6: Profiles key players, presenting core information on leading companies, including product sales, revenue, pricing, gross margin, product portfolio/introductions, and recent developments.
Chapter 7: Reviews the industry value chain, including upstream and downstream segments.
Chapter 8: Discusses market dynamics and recent developments, including drivers, restraints, challenges and risks for manufacturers, U.S. Tariffs and relevant policy analysis.
Chapter 9: Summarizes the key findings and conclusions of the report.

1 Endobronchial Blocker Market Overview
1.1 Product Definition
1.2 Endobronchial Blocker by Type
1.2.1 Global Endobronchial Blocker Market Value by Type: 2025 vs 2032
1.2.2 5Fr
1.2.3 7Fr
1.2.4 9Fr
1.3 Endobronchial Blocker by Application
1.3.1 Global Endobronchial Blocker Market Value by Application: 2025 vs 2032
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Others
1.4 Global Endobronchial Blocker Market Size Estimates and Forecasts
1.4.1 Global Endobronchial Blocker Revenue 2021–2032
1.4.2 Global Endobronchial Blocker Sales 2021–2032
1.4.3 Global Endobronchial Blocker Market Average Price (2021–2032)
1.5 Assumptions and Limitations

2 Endobronchial Blocker Market Competition by Manufacturers
2.1 Global Endobronchial Blocker Sales Market Share by Manufacturers (2021–2026)
2.2 Global Endobronchial Blocker Revenue Market Share by Manufacturers (2021–2026)
2.3 Global Endobronchial Blocker Average Price by Manufacturers (2021–2026)
2.4 Global Key Players of Endobronchial Blocker, Industry Ranking, 2023 vs 2024 vs 2025
2.5 Global Key Manufacturers of Endobronchial Blocker, Manufacturing Sites and Headquarters
2.6 Global Key Manufacturers of Endobronchial Blocker, Product Types and Applications
2.7 Global Key Manufacturers of Endobronchial Blocker, Date of Entry into the Industry
2.8 Global Endobronchial Blocker Market Competitive Situation and Trends
2.8.1 Global Endobronchial Blocker Market Concentration Rate
2.8.2 The Top 5 and Top 10 Global Endobronchial Blocker Players Market Share by Revenue
2.8.3 Global Endobronchial Blocker Market Share by Company Tier (Tier 1, Tier 2, Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans

3 Global Endobronchial Blocker Market Scenario by Region
3.1 Global Endobronchial Blocker Market Size by Region: 2021 vs 2025 vs 2032
3.2 Global Endobronchial Blocker Sales by Region: 2021–2032
3.2.1 Global Endobronchial Blocker Sales by Region: 2021–2026
3.2.2 Global Endobronchial Blocker Sales by Region: 2027–2032
3.3 Global Endobronchial Blocker Revenue by Region: 2021–2032
3.3.1 Global Endobronchial Blocker Revenue by Region: 2021–2026
3.3.2 Global Endobronchial Blocker Revenue by Region: 2027–2032
3.4 North America Endobronchial Blocker Market Facts & Figures by Country
3.4.1 North America Endobronchial Blocker Market Size by Country: 2021 vs 2025 vs 2032
3.4.2 North America Endobronchial Blocker Sales by Country (2021–2032)
3.4.3 North America Endobronchial Blocker Revenue by Country (2021–2032)
3.4.4 United States
3.4.5 Canada
3.5 Europe Endobronchial Blocker Market Facts & Figures by Country
3.5.1 Europe Endobronchial Blocker Market Size by Country: 2021 vs 2025 vs 2032
3.5.2 Europe Endobronchial Blocker Sales by Country (2021–2032)
3.5.3 Europe Endobronchial Blocker Revenue by Country (2021–2032)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Endobronchial Blocker Market Facts & Figures by Region
3.6.1 Asia Pacific Endobronchial Blocker Market Size by Region: 2021 vs 2025 vs 2032
3.6.2 Asia Pacific Endobronchial Blocker Sales by Region (2021–2032)
3.6.3 Asia Pacific Endobronchial Blocker Revenue by Region (2021–2032)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America Endobronchial Blocker Market Facts & Figures by Country
3.7.1 Latin America Endobronchial Blocker Market Size by Country: 2021 vs 2025 vs 2032
3.7.2 Latin America Endobronchial Blocker Sales by Country (2021–2032)
3.7.3 Latin America Endobronchial Blocker Revenue by Country (2021–2032)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Endobronchial Blocker Market Facts & Figures by Country
3.8.1 Middle East and Africa Endobronchial Blocker Market Size by Country: 2021 vs 2025 vs 2032
3.8.2 Middle East and Africa Endobronchial Blocker Sales by Country (2021–2032)
3.8.3 Middle East and Africa Endobronchial Blocker Revenue by Country (2021–2032)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE

4 Segment by Type
4.1 Global Endobronchial Blocker Sales by Type (2021–2032)
4.1.1 Global Endobronchial Blocker Sales by Type (2021–2026)
4.1.2 Global Endobronchial Blocker Sales by Type (2027–2032)
4.1.3 Global Endobronchial Blocker Sales Market Share by Type (2021–2032)
4.2 Global Endobronchial Blocker Revenue by Type (2021–2032)
4.2.1 Global Endobronchial Blocker Revenue by Type (2021–2026)
4.2.2 Global Endobronchial Blocker Revenue by Type (2027–2032)
4.2.3 Global Endobronchial Blocker Revenue Market Share by Type (2021–2032)
4.3 Global Endobronchial Blocker Price by Type (2021–2032)

5 Segment by Application
5.1 Global Endobronchial Blocker Sales by Application (2021–2032)
5.1.1 Global Endobronchial Blocker Sales by Application (2021–2026)
5.1.2 Global Endobronchial Blocker Sales by Application (2027–2032)
5.1.3 Global Endobronchial Blocker Sales Market Share by Application (2021–2032)
5.2 Global Endobronchial Blocker Revenue by Application (2021–2032)
5.2.1 Global Endobronchial Blocker Revenue by Application (2021–2026)
5.2.2 Global Endobronchial Blocker Revenue by Application (2027–2032)
5.2.3 Global Endobronchial Blocker Revenue Market Share by Application (2021–2032)
5.3 Global Endobronchial Blocker Price by Application (2021–2032)

6 Key Companies Profiled
6.1 Teleflex
6.1.1 Teleflex Company Information
6.1.2 Teleflex Description and Business Overview
6.1.3 Teleflex Endobronchial Blocker Sales, Revenue, and Gross Margin (2021–2026)
6.1.4 Teleflex Endobronchial Blocker Product Portfolio
6.1.5 Teleflex Recent Developments/Updates
6.2 Cook
6.2.1 Cook Company Information
6.2.2 Cook Description and Business Overview
6.2.3 Cook Endobronchial Blocker Sales, Revenue, and Gross Margin (2021–2026)
6.2.4 Cook Endobronchial Blocker Product Portfolio
6.2.5 Cook Recent Developments/Updates
6.3 PROACT Medical
6.3.1 PROACT Medical Company Information
6.3.2 PROACT Medical Description and Business Overview
6.3.3 PROACT Medical Endobronchial Blocker Sales, Revenue, and Gross Margin (2021–2026)
6.3.4 PROACT Medical Endobronchial Blocker Product Portfolio
6.3.5 PROACT Medical Recent Developments/Updates
6.4 NexGen Medical
6.4.1 NexGen Medical Company Information
6.4.2 NexGen Medical Description and Business Overview
6.4.3 NexGen Medical Endobronchial Blocker Sales, Revenue, and Gross Margin (2021–2026)
6.4.4 NexGen Medical Endobronchial Blocker Product Portfolio
6.4.5 NexGen Medical Recent Developments/Updates
6.5 Fuji Systems
6.5.1 Fuji Systems Company Information
6.5.2 Fuji Systems Description and Business Overview
6.5.3 Fuji Systems Endobronchial Blocker Sales, Revenue, and Gross Margin (2021–2026)
6.5.4 Fuji Systems Endobronchial Blocker Product Portfolio
6.5.5 Fuji Systems Recent Developments/Updates
6.6 Well Lead Medical
6.6.1 Well Lead Medical Company Information
6.6.2 Well Lead Medical Description and Business Overview
6.6.3 Well Lead Medical Endobronchial Blocker Sales, Revenue, and Gross Margin (2021–2026)
6.6.4 Well Lead Medical Endobronchial Blocker Product Portfolio
6.6.5 Well Lead Medical Recent Developments/Updates

7 Industry Chain and Sales Channels Analysis
7.1 Endobronchial Blocker Industry Chain Analysis
7.2 Endobronchial Blocker Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Endobronchial Blocker Production Mode & Process Analysis
7.4 Endobronchial Blocker Sales and Marketing
7.4.1 Endobronchial Blocker Sales Channels
7.4.2 Endobronchial Blocker Distributors
7.5 Endobronchial Blocker Customer Analysis

8 Endobronchial Blocker Market Dynamics
8.1 Endobronchial Blocker Industry Trends
8.2 Endobronchial Blocker Market Drivers
8.3 Endobronchial Blocker Market Challenges
8.4 Endobronchial Blocker Market Restraints
8.5 Impact of U.S. Tariffs

9 Research Findings and Conclusion

10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer